Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. | Canada Hyperbarics Skip to main content
Review Progress in neurobiology 2014

Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Stetler RA, Leak RK, Gan Y, Li P, Zhang F, Hu X, et al. — Progress in neurobiology, 2014

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

This review synthesized findings on preconditioning, a phenomenon where brief sublethal insults induce robust protection against subsequent lethal injuries, in various central nervous system disease models.

What They Found

Researchers found that preconditioning provides robust neuroprotection against at least five types of acute injuries, including ischemic stroke and neonatal hypoxia/ischemia, as well as models of neurodegenerative diseases like Parkinson's and Alzheimer's. This protection is achieved through numerous and diverse stimuli, such as transient ischemia and pharmacological agents, and involves multiple cellular defense mechanisms.

What This Means for Canadian Patients

An improved understanding of brain preconditioning could lead to innovative preventative or damage-reducing therapeutic strategies for Canadian patients at risk of neurological injuries like stroke or neurodegenerative diseases. These strategies might involve controlled exposure to specific stimuli to enhance the brain's natural resilience.

Canadian Relevance

This review does not explicitly mention any Canadian studies, researchers, or patient populations.

Study Limitations

The review's findings are largely based on extensive animal studies, indicating the need for further research to fully understand the complex mechanisms and translate preconditioning strategies effectively to human clinical applications.

Was this summary helpful?

Study Details

Study Type Review
Category Neurological
Source Pubmed
PubMed ID 24389580
Year Published 2014
Journal Progress in neurobiology
MeSH Terms Animals; Central Nervous System Diseases; Disease Models, Animal; Humans; Ischemic Preconditioning; Neuroprotective Agents

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.